Literature DB >> 1552304

Systemic lupus erythematosus presenting with neurological disorders.

M R Tola1, E Granieri, L Caniatti, E Paolino, C Monetti, L Dovigo, R Scolozzi, P De Bastiani, M Carreras.   

Abstract

Six patients are described who developed a wide variety of neurological manifestations heralding systemic lupus erythematosus (SLE), which included epileptic seizures, stroke, peripheral polyradiculoneuropathy similar to Guillain-Barré syndrome, transverse myelopathy and multifocal disorders with remitting course mimicking multiple sclerosis. The peculiarity of these cases was that the neurological disorders remained the only manifestations of SLE for many years and the nervous system appeared to be the main target even after the development of systemic SLE. In five patients the prognosis was favourable and corticosteroid treatment led to prolonged remission.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552304     DOI: 10.1007/bf00862972

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Neurologic signs and symptoms as early manifestations of systemic lupus erythematosus.

Authors:  R G SIEKERT; E C CLARK
Journal:  Neurology       Date:  1955-02       Impact factor: 9.910

Review 2.  The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.

Authors:  S R Levine; K M Welch
Journal:  Arch Neurol       Date:  1987-08

3.  Neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

4.  The neurological manifestations of systemic lupus erythematosus.

Authors:  R T Johnson; E P Richardson
Journal:  Medicine (Baltimore)       Date:  1968-07       Impact factor: 1.889

5.  A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature.

Authors:  R S April; E Vansonnenberg
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

6.  Cranial computed tomography in the diagnosis of systemic lupus erythematosus.

Authors:  F Gonzalez-Scarano; R P Lisak; L T Bilaniuk; R A Zimmerman; P C Atkins; B Zweiman
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

7.  Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.

Authors:  E N Harris; A E Gharavi; R A Asherson; M L Boey; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

8.  Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus.

Authors:  J Ernerudh; T Olsson; F Lindström; T Skogh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

9.  Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; G W Williams; A D Steinberg
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

10.  Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

Authors:  O Devinsky; C K Petito; D R Alonso
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

View more
  12 in total

1.  [The rare coincidence of Guillain-Barré syndrome and myelitis].

Authors:  K Schulze Beerhorst; B Klein; M Oelerich; K Rieke
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

Review 2.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

3.  A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

Authors:  E Paolino; E Fainardi; P Ruppi; M R Tola; V Govoni; I Casetta; V C Monetti; E Granieri; M Carreras
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.

Authors:  J I O'Riordan; H L Gallagher; A J Thompson; R S Howard; D P Kingsley; E J Thompson; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  Fatigue in patients with lupus is not associated with disturbances in cerebral blood flow as detected by SPECT.

Authors:  Roald Omdal; Hans Sjöholm; Wenche Koldingsnes; Johan A Sundsfjord; Eva A Jacobsen; Gunnar Husby; Svein I Mellgren
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 6.  Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Authors:  B Kovacs; T L Lafferty; L H Brent; R J DeHoratius
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

7.  Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.

Authors:  G Valesini; R Priori; A Francia; G Balestrieri; A Tincani; P Airo; R Cattaneo; A Zambruni; B Troianello; M Chofflon
Journal:  Springer Semin Immunopathol       Date:  1994

8.  Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors.

Authors:  V Martinelli; G Comi; M Rovaris; M Filippi; B Colombo; T Locatelli; A Campi; M Rodegher; N Canal
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

9.  Electrophysiological evidence of "nerve entrapment syndromes" and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma).

Authors:  M Mondelli; C Romano; P D Della Porta; A Rossi
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

10.  Unusual aetiology of isolated lower motor neuron facial palsy: systemic lupus erythematosus presenting with cranial nerve palsy and nephritis.

Authors:  Nayef Mohammed Kazzaz; Rasha El-Rifai
Journal:  BMJ Case Rep       Date:  2013-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.